Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

NCT03587805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1672

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Tralokinumab

Sponsor

LEO Pharma